Evidence map›Paper›PMID 41361697›Full record

ArticleEMBO reports2026

OTX2 controls chromatin accessibility to direct somatic versus germline differentiation.

Elisa Barbieri, Ian Chambers

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elisa BarbieriCentre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland. Elisa.Barbieri@ed.ac.uk.ORCID 0009-0000-4050-6119
Ian ChambersCentre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland.ORCID 0000-0003-2605-1597

Funding

EC | H2020 | PRIORITY 'Excellent science' | H2020 Marie Skłodowska-Curie Actions (MSCA) H2020-MSCAIF-2018/843879UKRI | Medical Research Council (MRC) MR/T003162/1
6 · The paper itself

Abstract

The choice between somatic and germline fates is essential for species survival. This choice occurs in embryonic epiblast cells, as these cells are competent for both somatic and germline differentiation. The transcription factor OTX2 regulates this process, as Otx2-null epiblast-like cells (EpiLCs) form primordial germ cell-like cells (PGCLCs) with enhanced efficiency. Yet, how OTX2 achieves this function is not fully characterised. Here we show that OTX2 controls chromatin accessibility at specific chromatin loci to enable somatic differentiation. CUT&RUN for OTX2 and ATAC-seq in wild-type and Otx2-null embryonic stem cells and EpiLCs identifies regions where OTX2 binds and opens chromatin. Enforced OTX2 expression maintains accessibility at these regions and also induces opening of ~4000 somatic-associated regions in cells differentiating in the presence of PGC-inducing cytokines. Once cells have acquired germline identity, these additional regions no longer respond to OTX2 and remain closed. Our results indicate that OTX2 works in cells with dual competence for somatic and germline differentiation to increase accessibility of somatic regulatory regions and induce the somatic fate at the expense of the germline.

Indexed as

Cell DifferentiationChromatinGerm CellsOtx Transcription FactorsAnimalsEmbryonic Stem CellsGene Expression Regulation, DevelopmentalGerm LayersMiceMouse Embryonic Stem CellsChromatinOtx2 protein, mouseOtx Transcription FactorsChromatin AccessibilityFormative PluripotencyGermlineOTX2

Identifiers

PMID41361697
PMCPMC12852747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.